Research Work in Progress
Novel software tools for extracting additional clinical value from DBT reconstructions
Simon Lowes1,2, David Joyce3, Ben Lopez3, Paul Scott3, Alice Leaver1
1Gateshead Health NHS Foundation Trust, Gateshead, United Kingdom. 2Newcastle University, Newcastle upon Tyne, United Kingdom. 3IBEX Innovations Ltd, Sedgefield, United Kingdom
Correspondence: David Joyce
Scientific—Axilla
New pulse biopsy device proved to be safe and effective in axillary lymph nodes with pulsed insertion facilitating enhanced needle control: Initial results from the German multi-center PULSE study
Marc Thill1, Thorsten Kühn2, Uwe Peisker3, Angrit Stachs4, Mattea Reinisch5, Wolfram Malter6, Ines Gruber7, Stefan Paepke8, Magnus Olsen9, Kai-Uwe Schässburger9
1Agaplesion Markus Hospital, Frankfurt, Germany. 2Klinikum Esslingen, Esslingen, Germany. 3Hermann-Josef-Krankenhaus, Erkelenz, Germany. 4Klinikum Südstadt Rostock, Rostock, Germany. 5Klinken Essen Mitte, Essen, Germany. 6University Hospital Köln, Köln, Germany. 7University Hospital Tübingen, Tübingen, Germany. 8University Hospital r.d. Isar of TU München, München, Germany. 9Neodynamics, Lidingö, Sweden
Correspondence: Marc Thill
Scientific—Breast MR
Investigation of Sternal Lesions Identified by Breast MRI
Fotini Asprou, Hassan Rehman, Zatinahhayu Mohd Isa
Royal Stoke University Hospital, University Hospital of North Midlands NHS Trust, Stoke-On-Trent, United Kingdom
Correspondence: Fotini Asprou
Scientific—Breast US
Management of additional lesions detected on Staging and Problem-solving Breast MRI – DGH Experience
Tania Mercado, Nithya Vidyaprakash, Asha Eleti
Southend University Hospital, Southend on Sea, United Kingdom
Correspondence: Tania Mercado
Audit on the efficacy and accuracy of the elastography usage in conjunction with B- mode ultrasound for suspected breast lumps in the symptomatic one stop breast clinic setting
Guneesh Dadayal, Sophie Levine, Susan Oates, Rachael Brass
Airedale General Hospital, Keighley, United Kingdom
Correspondence: Guneesh Dadayal
Single centre assessment of usefulness of shear- wave elastography in assessment of symptomatic breast lesions
Ajit Dhillon, Eddie Gibson, Calvin Ng
Antrim Area Hospital, Antrim, United Kingdom
Correspondence: Ajit Dhillon
Scientific—High Risk Screening
Very High-risk breast screening at King’s College Hospital - A 5-year review
Monica Patil, Clare Peacock, Shalini Wijesuriya, Michael Michell, Rema Wasan, Keshtra Satchithananda, Nikhil Patel, Bhavna Batohi, Rumana Rahim, Juliet Morel
King's College Hospital, London, United Kingdom
Correspondence: Monica Patil
Scientific—Mammography
The creation of a breast screening image database – The Cambridge Cohort – Mammography East-Anglia Digital Imaging Archive (CC-MEDIA)
Sarah Hickman1, Sue Hudson2, Nicholas Payne1, Richard Black3, Bahman Kasmai4, Andrew Priest3, Arne Juette4, Fiona Gilbert1,3
1University of Cambridge, Cambridge, United Kingdom. 2PAS Consulting, London, United Kingdom. 3Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom. 4Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom
Correspondence: Sarah Hickman
Analysis of enhancement intensity and patterns of benign and malignant lesions on contrast-enhanced Spectral Mammography
Anam Ali, Tamara Suaris
Barts Health NHS Trust, London, United Kingdom
Correspondence: Anam Ali
Audit of DBT guided biopsies in ultrasound occult soft tissue abnormalities - A 3-year review
Monica Patil, Rema Wasan, Michael Michell, Shalini Wijesuriya, Clare Peacock, Nikhil Patel, Rumana Rahim, Bhavna Batohi, Keshtra Satchithananda, Juliet Morel
King's College Hospital, London, United Kingdom
Correspondence: Monica Patil
Scientific—Procedures
A single centre experience of providing an MRI guided breast biopsy service
Dr Maame Akua Akobeng, Dr Trupti Kulkarni, Dr Caroline Parkin
The Nightingale Centre, Wythenshawe Hospital, Manchester, United Kingdom
Correspondence: Dr Maame Akua Akobeng
Localizing non-palpable breast lesions in a pandemic: RFID Tag evaluation
Ivy Okereke, Rupika Mehta, Asma Javed, Anil Madhavan, Chidinma Igu, Jocelyn Jaudalso, Rachel Merrett
Medway Maritime Hospital, Gillingham, Kent, United Kingdom
Correspondence: Ivy Okereke
Localisation of non-palpable breast lesions prior to surgical excision: An evaluation of ultrasound guided RFID tag localisation vs guidewire localisation
Louise Dodgeon
North Cumbria Integrated Care NHS Foundation Trust, Carlisle, United Kingdom
Correspondence: Louise Dodgeon
Optimal needle assessment for M3-M5 microcalcification
Ivy Okereke
MEDWAY MARITIME HOSPITAL, GILLINGHAM, United Kingdom
Correspondence: Ivy Okereke
A study comparing Hologic LOCalizer seeds to wire guided localisation for clinically impalpable breast lesions
Sonali Shah, Natalie Allen, Vishnu Parameshwaran, Tamara Suaris
Barts Health NHS Trust, London, United Kingdom
Correspondence: Sonali Shah
Use of LOCalizer RFID tags in the pre-operative localisation of axillary lymph nodes
Sarrah El-Tahir1, Sharon Koo1, Robert Milligan1, Sunil Amonkar1, Alice Leaver1, Simon Lowes1,2
1Gateshead Health NHS Foundation Trust, Gateshead, United Kingdom. 2Newcastle University, Newcastle upon Tyne, United Kingdom
Correspondence: Sarrah El-Tahir
Stereotactic insertion of LOCalizer RFID tags for pre-operative localisation of breast cancer
Sharon Koo1, Sarrah El Tahir1, Robert Milligan1, Sunil Amonkar1, Alice Leaver1, Simon Lowes1,2
1Gateshead Health NHS Foundation Trust, Gateshead, United Kingdom. 2Newcastle University, Newcastle upon Tyne, United Kingdom
Correspondence: Sharon Koo
Scientific—Screening
Audit of whole breast verses quadrant ultrasound in screening breast imaging
Lucinda Frank, Helen Massey
North Bristol NHS Trust, Bristol, United Kingdom
Correspondence: Lucinda Frank
A pilot analysis to determine impact of round length on interval cancer rates in the English Breast Screening Programme
Matthew Wallis1, Alison Murphy2, Kim Mellor2, Jackie Walton2, Mike Press2, Daniel Vulkan3, Stephen Duffy3, Olive Kearins2
1Cambridge Breast Unit, Cambridge, United Kingdom. 2Screening QA Service PHE Screening, Birmingham, United Kingdom. 3Quenn Mary University, London, United Kingdom
Correspondence: Matthew Wallis
“Hindsight is a wonderful thing”: A review of Interval Cancers diagnosed in our breast screening unit over a 14 month period
Matthew Murphy, Paula Hynam, Sarah Perrin, Emma Jackson
Musgrove Park Hospital, Taunton, United Kingdom
Correspondence: Matthew Murphy
-
Breast screening: reporting, classification and monitoring of interval cancers and cancers following previous assessment (Public Health England, 2021)
Is It Practical to Vary Breast Screening Intervals According to the Risks of Developing Breast Cancer?
Wendy Tan, Susan Astley, Elaine Harkness, Gareth Evans
University of Manchester, Manchester, United Kingdom
Correspondence: Wendy Tan
Analysis of clinical, radiological, pathological features and outcome of mucinous breast carcinoma- retrospective study in a large UK teaching hospital
Amil Chaudhry, Pragya Singh, Jonathan Shadwell, Shams Vaquas, Abeer Shaaban, Shekhar Kaneri
Queen Elizabeth Hospital, Birmingham, United Kingdom
Correspondence: Pragya Singh
-
Clinical: A total of 53 cases were reviewed (median age 70 years, range 38 – 93), including one male patient. 28/53 (53%) were screening patients, 18/53 (34%) diagnosed via symptomatic one-stop breast clinic and 7/53 (13%) as an incidental finding.
-
Radiological: 48/49 (98%) of mammograms were abnormal. Mass/masses (average size 25.7 mm, range 5-97 mm) on 42/49 (86%) and asymmetric density on 6/49 (12%). On 45/47 breast ultrasounds (96%), a mass was identified. 8/50 (16%) showed metastatic axillary lymph nodes.
-
Pathological: Histological grades and receptors were as follows: (grade I (20%), grade II (49%) and grade III (2%)) and receptor status [(98% (50/51) ER positive, 97.6% (41/42) PR positive and only 2% (1/51) HER2 positive].
-
Treatment: 44/52 (85%) patients underwent surgical resection with majority (70%) undergoing wide local excision and 30% mastectomy. 6 /8 (75%) patients with metastatic axillary lymph nodes at presentation died by the time of data collection.